ReviewGerman medical science : GMS e-journal2026
Insights into systematic reviews and meta-analyses: Are we judgmental enough?
Review in German medical science : GMS e-journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systematic reviews (SRs) and meta-analyses are regarded as the pinnacle of evidence-based medicine, synthesizing fragmented research to guide clinical decision-making. However, the exponential increase in their publication has raised concerns regarding redundancy, methodological flaws, and misleading conclusions. Many SRs lack preregistration, employ inconsistent methodologies, and fail to account for clinical heterogeneity. Additionally, the integration of artificial intelligence (AI) in research poses new challenges, including data fabrication, plagiarism, and AI-induced biases. While AI offers efficiency in processing vast amounts of data, its unregulated use may compromise research integrity. Furthermore, current review processes often overlook critical clinical insights, leading to misinterpretations. To improve SR quality, a rigorous, stepwise approach is necessary, including preregistration, comprehensive literature searches, unbiased data abstraction, and meticulous assessment of confounding factors. AI-generated content must be scrutinized through human oversight to ensure accuracy and reliability. Ultimately, the overreliance on statistical aggregation without critical clinical evaluation may lead to flawed conclusions. Clinicians must actively engage in assessing SRs beyond methodological frameworks, integrating human judgment to enhance the credibility and applicability of findings. Addressing these challenges is crucial for maintaining the integrity of evidence-based medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.